Boston Scientific Stent Suit Seeks Injunctive Relief From J&J Market Entry
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's stent patent suit against Johnson & Johnson's Cordis unit follows by ten days an agreement between J&J and Guidant to co-develop balloon dilatation catheters on a rapid-exchange platform.
You may also be interested in...
Boston Scientific v. J&J
U.S. District Court in Delaware awards Boston Scientific and its stent supplier Medinol $8.3 mil. in damages after finding Johnson & Johnson's Corinthian stent infringes a valid Medinol patent claim, Boston Scientific announced Sept. 7. The jury also found that J&J's Bx Velocity, Crown and Mini Crown stents do not infringe patents owned by Medinol; the complaint was filed in April 2000 (1"The Gray Sheet" May 1, 2000, p. 15). Boston Scientific plans to appeal the mixed verdict if the judge will not agree to set aside the jury's decision
Boston Scientific v. J&J
U.S. District Court in Delaware awards Boston Scientific and its stent supplier Medinol $8.3 mil. in damages after finding Johnson & Johnson's Corinthian stent infringes a valid Medinol patent claim, Boston Scientific announced Sept. 7. The jury also found that J&J's Bx Velocity, Crown and Mini Crown stents do not infringe patents owned by Medinol; the complaint was filed in April 2000 (1"The Gray Sheet" May 1, 2000, p. 15). Boston Scientific plans to appeal the mixed verdict if the judge will not agree to set aside the jury's decision
J&J To Appeal German Stent Patent Suit Ruling In Favor Of Boston Scientific
Johnson & Johnson is in the process of filing an appeal of a May 15 German court ruling that its BX Velocity coronary stent infringes patented Boston Scientific NIR stent technology, the firm says. Boston Scientific is seeking an injunction and damages based on sales.